Puma Biotechnology Inc. (PBYI)
NASDAQ · Healthcare
Puma Biotechnology Inc. Revenue 2017–2025
Puma Biotechnology Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Puma Biotechnology Inc. revenue for the quarter ending March 31, 2026 was 44.8 M, a 2.59% decrease year-over-year.
- Puma Biotechnology Inc. revenue for the twelve months ending March 31, 2026 was 197.7 M, a 13.09% decrease year-over-year.
- Puma Biotechnology Inc. annual revenue for 2025 was 228.4 M, a 0.91% decrease from 2024.
- Puma Biotechnology Inc. annual revenue for 2024 was 230.5 M, a 2.19% decrease from 2023.
- Puma Biotechnology Inc. annual revenue for 2023 was 235.6 M, a 3.34% increase from 2022.
- Puma Biotechnology Inc. annual revenue for 2022 was 228.0 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Puma Biotechnology Inc. Revenue — FAQ
Puma Biotechnology Inc. (PBYI) revenue over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Puma Biotechnology Inc.'s revenue?
Puma Biotechnology Inc. (PBYI) reported revenue of $228M for fiscal 2025.
Where can I see PBYI's revenue history?
The chart and table above show Puma Biotechnology Inc.'s revenue by year and by quarter, including the growth rate.